All In Biotech

Drug Trial Radar · NCT01290445

Varenicline Pregnancy Cohort Study

Varenicline Pregnancy Cohort Study Protocol Chantix(Registered)/Champix(Registered) (Varenicline Tartrate)

Last checked: Nov 19, 2026Latest source record: Jul 24, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

885,185

Actual

Start

Sep 13, 2007

Primary completion

May 1, 2016

Study completion May 1, 2016

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
Collaborators
University of Aarhus; Karolinska Institutet
First posted
Feb 7, 2011

More drug trials from this sponsor

Design

Study type
Observational
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A prospective population-based cohort study to examine whether varenicline use during pregnancy is associated with an increased risk of major congenital malformations in infants above that associated with smoking during pregnancy.

Conditions

  • Malformations

Interventions

  • vareniclineDrug

    This is a non-interventional study. Exposure in utero to varenicline is observed, not assigned.

  • cigarette smoke from maternal smokingBehavioral

    This is a non-interventional study. Exposure in utero to cigarette smoke from maternal smoking is observed, not assigned.

  • Non-ExposureOther

    This is a non-interventional study. Non-exposure in utero to varenicline and cigarette smoke from maternal smoking is observed, not assigned.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Infants With Major Congenital MalformationsTime frame: For 12 months after birth

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.